See the rest here:
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
Category Archives: Global News Feed
RespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine
Palisade Bio Provides Corporate Update and Reiterates Guidance
The rest is here:
Palisade Bio Provides Corporate Update and Reiterates Guidance
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy…
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
Telomir Pharmaceuticals Announces Closing of Initial Public Offering
Go here to read the rest:
Telomir Pharmaceuticals Announces Closing of Initial Public Offering
Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Originally posted here:
Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation…
Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
Voting Rights and Shares Capital of the Company
See original here:
Voting Rights and Shares Capital of the Company
Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in…
PCI Biotech second half 2023 interim results
See original here:
PCI Biotech second half 2023 interim results
Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced…
Mendus AB Year-end Report for 2023
Original post:
Mendus AB Year-end Report for 2023
Ultimovacs ASA Reports Fourth Quarter 2023 Financial Results and Provides General Business Update
Read more from the original source:
Ultimovacs ASA Reports Fourth Quarter 2023 Financial Results and Provides General Business Update
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
Read more from the original source:
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound